← Eichor
Study identifier: NCT06853340 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock

Condition: Septic Shock · Calcium Sensing Receptor · Calcium Phosphate Disorders  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseNA
Planned participants66
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

In septic shock, bacterial LPS is able to activate the CaSR of cardiomyocytes inducing their apoptosis in vitro. CaSR activation in monocytes is responsible for activation of the NLRP3 inflammasome and macropinocytosis. In front of this immune axis, a variation in the monocyte expression of the CaSR is expected in the state of shock. This is already observed in other pathologies such as renal failure or in animal models of severe burns. If this is considered as an overall reflection of CaSR expression in the body, it would be consistent with the phosphocalcic disturbances associated with septic shock. The phosphocalcic balance is often modified, and not treated during the acute episode, with in particular hypocalcaemia which could be consecutive to a hyperactivation or overexpression of the CaSR. This study proposes to explore for the first time the expression of monocytic CaSR in patients in a state of shock, with possible therapeutic perspectives by the existence of calcimimetics and calcilytics. In this study, the investigators propose to explore the CasR and its implication in septic shock in a three - part protocol : measurement by flow cytometry of monocyte expression of CASR (primary objective) and CD33, CD14, CD163, CD16 and HLA-DR), survey of clinical and biological parameters in patients with septic shock and healthy volunteers and acquisition of calcium score in patients with septic shock.

This description comes directly from the study's public registry record.

Talk to the study team

Quintana SOULIER  ·  33+322057870  ·  Soulier-Zaninka.Quintana@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHRU AmiensAmiens, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06853340